NEW YORK, Sept. 24 /PRNewswire/ -- Intellectual property attorney Jason Lief has joined Gersten Savage LLP as a partner, the firm announced. He is co-chair of the firm's intellectual property practice with partner James Fornari. Lief's practice focuses on patent and intellectual property litigation and counseling, with a particular concentration on the pharmaceutical industry.
Lief has successfully represented clients in several dozen major patent litigations, including Hatch-Waxman cases involving billion-dollar pharmaceutical products and matters concerning other cutting-edge technologies. His extensive trial and litigation experience includes trying patent infringement, validity and enforceability issues before United States federal judges and juries; arguing before the U.S. Court of Appeals for the Federal Circuit; and managing and conducting all aspects of discovery, including foreign court appearances pursuant to the Hague Convention.
He has represented major pharmaceutical companies and has handled matters spanning organic chemistry, biotechnology, antibodies, combinatorial chemistry, RNAi technology, antibiotics, anti-depressants, anti-retroviral and anti-ulcer medicines, sustained-release medicines, drug-stabilization, polymers, advanced battery systems, detergents and deodorant technologies.
"We are very pleased to welcome Jason on board. He brings extensive experience to the firm, particularly in the area of pharmaceutical patents and IP," said Jay Kaplowitz, Gersten Savage managing partner. "Together with IP practice co-chair Jim Fornari, we can provide clients with expertise in a wide array of intellectual property matters."
Prior to joining Gersten Savage, Lief was a partner with McDermott, Will & Emery. Previously, he was a partner with Morgan Lewis & Bockius. He began his career as an associate and then a partner at Hopgood, Calimafde,
|SOURCE Gersten Savage LLP|
Copyright©2009 PR Newswire.
All rights reserved